Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Population Genetics?01:25

What is Population Genetics?

64.5K
A population is composed of members of the same species that simultaneously live and interact in the same area. When individuals in a population breed, they pass down their genes to their offspring. Many of these genes are polymorphic, meaning that they occur in multiple variants. Such variations of a gene are referred to as alleles. The collective set of all the alleles within a population is known as the gene pool.
64.5K
Conservation of Small Populations02:04

Conservation of Small Populations

16.7K
Small population sizes put a species at extreme risk of extinction due to a lack of variation, and a consequent decrease in adaptability. This weakens the chances of survival under pressures such as climate change, competition from other species, or new diseases. Large populations are more likely to survive pressures such as these, as such populations are more likely to harbor individuals that have genetic variants that are adaptive under new stresses. Small populations are much less...
16.7K
Population Growth00:57

Population Growth

28.1K
Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.1K
What are Populations and Communities?00:30

What are Populations and Communities?

37.4K
Overview
37.4K
Levels of Organization01:09

Levels of Organization

139.2K
Biological organization is the classification of biological structures, ranging from atoms at the bottom of the hierarchy to the Earth's biosphere. Each level of the hierarchy represents an increase in complexity that builds upon the previous level.
Molecules Are Composed of Atoms, and Biomolecules Are Assembled from Molecules:
The most basic levels include atoms, molecules, and biomolecules. Atoms, the smallest unit of ordinary matter, are composed of a nucleus and electrons. Molecules...
139.2K
High-Level and Low-Level Awareness01:19

High-Level and Low-Level Awareness

632
Controlled processes in human consciousness represent high-alert mental states where individuals deliberately focus their attention on achieving specific goals. Controlled processes can be seen in situations like mastering new technology, where a person might become so absorbed that they ignore surrounding distractions. Such processes involve selective attention, requiring one to concentrate on particular elements of experience while disregarding others. These are governed by executive...
632

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Dupilumab in difficult-to-treat bullous pemphigoid at the University Hospital Schleswig-Holstein, Campus Kiel.

Frontiers in medicine·2026
Same author

Endocannabinoid analysis in GlucoEXACT plasma: Method validation and sample handling recommendations.

Talanta·2024
Same author

Metabolomic and lipidomic fingerprints in inflammatory skin diseases - Systemic illumination of atopic dermatitis, hidradenitis suppurativa and plaque psoriasis.

Clinical immunology (Orlando, Fla.)·2024
Same author

Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO).

Dermatology and therapy·2024
Same author

Clinical and molecular response to dupilumab treatment in pediatric atopic dermatitis: Results of the German TREATkids registry.

Allergy·2024
Same author

Effectiveness, safety and impact of guselkumab on sexuality and perceived stigmatization in patients with psoriasis in routine clinical practice: Week 28 results from the prospective German multicentre G-EPOSS study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Related Experiment Video

Updated: Jan 23, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K

Adiponectin levels in a large pooled plaque psoriasis study population.

S Gerdes1, A Pinter2, M Biermann3

  • 1Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.

The Journal of Dermatological Treatment
|June 11, 2019
PubMed
Summary

Adiponectin levels in psoriasis patients are primarily determined by metabolic syndrome and body mass index (BMI). Psoriasis severity and treatments like secukinumab/etanercept showed minimal impact on adiponectin.

Keywords:
AdiponectinBMImetabolic syndromepsoriasis

More Related Videos

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

785
Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
10:54

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations

Published on: September 17, 2012

11.0K

Related Experiment Videos

Last Updated: Jan 23, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

785
Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
10:54

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations

Published on: September 17, 2012

11.0K

Area of Science:

  • Endocrinology
  • Dermatology
  • Metabolic Syndrome Research

Background:

  • Adiponectin, an adipocyte-secreted protein, is implicated in the cardiometabolic comorbidities observed in psoriasis patients.
  • Understanding adiponectin's role is crucial for managing psoriasis comorbidities.

Purpose of the Study:

  • To investigate the influence of obesity, metabolic syndrome, psoriasis severity, and treatments (secukinumab/etanercept) on adiponectin levels.
  • To analyze the relationship between adiponectin and key clinical parameters in psoriasis.

Main Methods:

  • A post-hoc analysis of three Phase III clinical trials involving patients with moderate to severe plaque psoriasis.
  • Correlations between Psoriasis Area and Severity Index (PASI), body mass index (BMI), comorbidities, and adiponectin levels were assessed.
  • The impact of secukinumab, etanercept, and placebo on adiponectin over 52 weeks was evaluated.

Main Results:

  • Adiponectin levels were inversely correlated with BMI (r = -0.23, p < .0001) and lower in patients without metabolic syndrome.
  • A weak, clinically irrelevant negative association was found between PASI scores and adiponectin levels (r = -0.065, p = .0004).
  • Adiponectin levels remained stable during 52 weeks of treatment with secukinumab or etanercept.

Conclusions:

  • Metabolic syndrome and BMI are significant determinants of adiponectin levels in psoriasis patients.
  • Psoriasis severity, as measured by PASI, does not have a clinically relevant impact on adiponectin.
  • Anti-psoriatic treatments with secukinumab or etanercept did not significantly alter adiponectin levels.